Research Updates

Back to project

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome): update of October 12, 2026

What's new and why it matters

  1. A review discusses new therapies aimed at improving outcomes for people with hereditary hemorrhagic telangiectasia (HHT). Based on: 1
  2. A young man’s bleeding issue related to HHT highlights the importance of careful management for this condition. Based on: 2
  3. A planned study will assess the safety of TX002100 and its potential to reduce the need for blood treatments in HHT patients. Based on: 3
  4. Research shows that RUNX3 is vital for blood vessel stability, which may relate to conditions like hereditary hemorrhagic telangiectasia. Based on: 4
  5. A review explores the risks of neurological issues after surgery for brain malformations in people with hereditary hemorrhagic telangiectasia. Based on: 7

Materials in this update

  1. Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia.
    PubMed

    Oct 11, 2026

    A review discusses new therapies for hereditary hemorrhagic telangiectasia (HHT), including treatments that aim to improve patient outcomes.

  2. A 23-Year-Old Man With Hemoptysis and Expectoration of a Metal Fragment.
    PubMed

    Oct 8, 2026

    A case report details a young man's bleeding issue linked to hereditary hemorrhagic telangiectasia, highlighting the need for careful management.

  3. Phase 1b Study of TX002100 in Participants With Hematologic Support-Dependent Hereditary Hemorrhagic Telangiectasia (HHT)
    Clinical trials

    Registered study, no results yet

    Oct 7, 2026

    A study will evaluate the safety of TX002100 in patients with hereditary hemorrhagic telangiectasia and its impact on reducing blood treatment needs.

  4. RUNX3-ERG Cooperation Orchestrates Endothelial Gene Regulation and Vascular Homeostasis.
    PubMed

    Oct 7, 2026

    Research shows that RUNX3 plays a key role in blood vessel stability, with potential implications for vascular disorders like hereditary hemorrhagic telangiectasia.

  5. Subarachnoid haemorrhage in paediatric hereditary haemorrhagic telangiectasia: a case report and literature review.
    PubMed

    Oct 5, 2026

    This case report discusses a rare instance of subarachnoid hemorrhage in a child with hereditary hemorrhagic telangiectasia, underscoring the importance of monitoring.

  6. Case Report: A pediatric case of multifocal Streptococcus intermedius brain abscesses as the initial manifestation of SMAD4-associated juvenile polyposis-hereditary hemorrhagic telangiectasia overlap syndrome.
    PubMed

    Sep 24, 2026

    A report describes a child with multiple brain abscesses linked to hereditary hemorrhagic telangiectasia, emphasizing the need for genetic evaluation.

  7. Permanent neurological morbidity after microsurgical resection of hereditary hemorrhagic telangiectasia-associated brain arteriovenous malformations: a systematic review and illustrative case.
    PubMed

    Sep 22, 2026

    A systematic review examines the risks of neurological problems after surgery for brain malformations in patients with hereditary hemorrhagic telangiectasia.

  8. From imaging to impact: A case of renal arteriovenous malformation.
    PubMed

    Sep 22, 2026

    A case study presents successful treatment of a kidney malformation using embolization, showing a safe approach to managing unexplained bleeding.

  9. Safety of antithrombotic therapy in hereditary hemorrhagic telangiectasia: results from a prospective cohort study.
    PubMed

    Sep 3, 2026

    A study found that antithrombotic therapy is generally safe for patients with hereditary hemorrhagic telangiectasia, with few significant bleeding events.

  10. Selumetinib for pediatric arteriovenous malformation with a MAP2K1 variant identified by liquid biopsy of nidus-draining venous blood.
    PubMed

    Sep 2, 2026

    A case report indicates that Selumetinib may effectively reduce the size of arteriovenous malformations in children with a specific genetic mutation.

  11. Dermoscopy of Capillary Malformations in Capillary Malformation-Arteriovenous Malformation Syndrome Type 2.
    PubMed

    Jul 31, 2026

    This letter analyzes unique skin features linked to a specific vascular syndrome, aiding accurate diagnosis and treatment planning.

  12. Nonsurgical Management of a Challenging Auricular Arteriovenous Malformation Using Serial Embolization and Sclerotherapy.
    PubMed

    Mar 25, 2026

    A case study highlights the success of non-surgical methods in treating a difficult ear malformation, improving patient outcomes without major surgery.

  13. Demarcation Procedure: An Effective and Safe Method before Definitive Resection of Large Arteriovenous Malformations.
    PubMed

    Feb 6, 2026

    A study explores a new surgical approach that could reduce bleeding during arteriovenous malformation removal, improving safety during complex procedures.

All updates for Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu syndrome)
Email language